Abstract
The notion that protein-coding genes are the only biologically significant moieties in the genome is revolutionarized by the discovery of non-coding RNAs. Among them is a group of small non-coding RNAs termed microRNAs (miRNAs) that has recently been brought to the limelight. Their presence in the genome was only realized after the identification of their founders lin-4 and let-7 in C. elegans through genetic screens. To date, several hundreds of microRNAs have been identified. They are single-stranded RNA molecules of ∼21-22 nucleotides long, excised from precursors of ∼70 nucleotides predicted in silico to from imperfect stem-loop structures. Many of these miRNAs are evolutionarily conserved, implicating important biological functions. Emerging data points to an important role of these tiny RNA molecules in regulating gene expression of target RNAs by at least two post-transcriptional mechanisms: binding to imperfect complementary sequence of the 3 untranslated region (3UTR) and repressing translation; and endonucleolytic cleavage by a double-stranded RNA-mediated interference (RNAi) mechanism through base-pairing with perfect or near-perfect complementary sequence. Studies in several miRNAs in plants and animals illustrate that these small riboregulators can play critical roles in developmental timing and spatial control of cell fate decisions, cell proliferation, apoptosis, cell differentiation and cell metabolism. Developmental defects and tumorigenesis can be a consequence of abnormal expression of miRNAs. This review discusses the biological functions, mechanisms of action, biogenesis and regulation of miRNAs, as well as identification of their target genes, highlighting the potential diversity of this novel class of gene regulators.
Keywords: microrna, gene regulation, untranslated region, translation
Current Genomics
Title: MicroRNAs: Tiny but Not Trivial
Volume: 5 Issue: 3
Author(s): Wayne Tam
Affiliation:
Keywords: microrna, gene regulation, untranslated region, translation
Abstract: The notion that protein-coding genes are the only biologically significant moieties in the genome is revolutionarized by the discovery of non-coding RNAs. Among them is a group of small non-coding RNAs termed microRNAs (miRNAs) that has recently been brought to the limelight. Their presence in the genome was only realized after the identification of their founders lin-4 and let-7 in C. elegans through genetic screens. To date, several hundreds of microRNAs have been identified. They are single-stranded RNA molecules of ∼21-22 nucleotides long, excised from precursors of ∼70 nucleotides predicted in silico to from imperfect stem-loop structures. Many of these miRNAs are evolutionarily conserved, implicating important biological functions. Emerging data points to an important role of these tiny RNA molecules in regulating gene expression of target RNAs by at least two post-transcriptional mechanisms: binding to imperfect complementary sequence of the 3 untranslated region (3UTR) and repressing translation; and endonucleolytic cleavage by a double-stranded RNA-mediated interference (RNAi) mechanism through base-pairing with perfect or near-perfect complementary sequence. Studies in several miRNAs in plants and animals illustrate that these small riboregulators can play critical roles in developmental timing and spatial control of cell fate decisions, cell proliferation, apoptosis, cell differentiation and cell metabolism. Developmental defects and tumorigenesis can be a consequence of abnormal expression of miRNAs. This review discusses the biological functions, mechanisms of action, biogenesis and regulation of miRNAs, as well as identification of their target genes, highlighting the potential diversity of this novel class of gene regulators.
Export Options
About this article
Cite this article as:
Tam Wayne, MicroRNAs: Tiny but Not Trivial, Current Genomics 2004; 5 (3) . https://dx.doi.org/10.2174/1389202043349435
DOI https://dx.doi.org/10.2174/1389202043349435 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting the Cancer Biomarker CD47: A Review on the Diverse Mechanisms of the CD47 Pathway in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Aerosol Delivery in the Treatment of Lung Cancer
Current Cancer Drug Targets JAK/STAT Signal Transduction: Promising Attractive Targets for Immune, Inflammatory and Hematopoietic Diseases
Current Drug Targets Application of NMR Spectroscopy in Medicinal Chemistry and Drug Discovery
Current Topics in Medicinal Chemistry New Prospects for Nelfinavir in Non-HIV-Related Diseases
Current Molecular Pharmacology Anti-TNF and Crohns Disease: When Should we Start?
Current Drug Targets An Update on MDMX and Dual MDM2/X Inhibitors
Current Topics in Medicinal Chemistry EZN-2208 (PEG-SN38), A 40 kDa Polyethylene Glycol (PEG) Conjugate, As an Anticancer Agent: Review of Preclinical and Clinical Data
Current Bioactive Compounds Effect of Curcumin on Pro-angiogenic Factors in the Xenograft Model of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Intracellular Fate of Peptide-Mediated Delivered Cargoes
Current Pharmaceutical Design Phosphorylation-Specific Prolyl Isomerase Pin1 as a new Diagnostic and Therapeutic Target for Cancer
Current Cancer Drug Targets Targeting the Brain: Advances in Drug Delivery
Current Pharmaceutical Biotechnology Editorial (Thematic Issue: Targeted Anti-Cancer Drug Delivery)
Current Cancer Drug Targets Identification of Essential 2D and 3D Chemical Features for Discovery of the Novel Tubulin Polymerization Inhibitors
Current Topics in Medicinal Chemistry Apoptosis Induction by Erucylphosphohomocholine via the 18 kDa Mitochondrial Translocator Protein: Implications for Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Cytochrome P450 Retinoic Acid 4-Hydroxylase Inhibitors: Potential Agents for Cancer Therapy
Mini-Reviews in Medicinal Chemistry Reconceptualizing Adult Neurogenesis: Role for Sphingosine-1-Phosphate and Fibroblast Growth Factor-1 in Co-Ordinating Astrocyte-Neuronal Precursor Interactions
CNS & Neurological Disorders - Drug Targets Toxic Epidermal Necrolysis and Antifolate Drugs in Cancer Chemotherapy
Current Drug Safety Using Natural Product Inhibitors to Validate Hsp90 as a Molecular Target in Cancer
Current Topics in Medicinal Chemistry Recent Advancements in 1,4-Disubstituted 1H-1,2,3-Triazoles as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry